Condor Software

Condor Software develops a financial intelligence platform purpose-built for life sciences organizations, specifically designed to manage R&D finance across clinical trial accounting, financial planning and analysis (FP&A), clinical operations, and internal audit functions. The platform is used by emerging and mid-sized biopharma companies, enterprise biopharma organizations, MedTech companies, and contract research organizations (CROs). Condor was founded by Jen Kyle, who drew on years of experience in pharma to build an enterprise-grade financial cloud intended to replace fragmented processes, disconnected systems, and manual workflows that slow clinical development.

The company has raised a $24 million Series A funding round led by Insight Partners. Condor has published thought leadership in partnership with PwC, including a white paper on evaluating clinical finance software, and has documented customer outcomes including a case study with Ventyx Biosciences, which reported improvements in efficiency, accuracy, and cross-team collaboration after implementing the platform.

Platform Modules

• Copilot: An AI-driven assistant designed to support users through each financial close and forecast cycle.
• Compass: A module focused on financial foresight and portfolio navigation, providing clarity for business decision-making.
• Connect: Integrates the broader R&D finance ecosystem, unifying data from ERP, CTMS, EDC, and procurement systems into a single source of truth.

Core Products

• Accounting: Provides enterprise-grade automation for R&D accruals, with purpose-built workflows designed to reduce time to close and improve accuracy.
• FP&A: Offers AI-driven R&D planning and predictive insights, including multi-variable scenario planning with the ability to forecast by region and cohort, add custom line items, and adjust activity drivers.
• Benchmarking and Advanced Analytics: Supports data-driven R&D financial decision-making through comparative and analytical tools.

Solutions by Function

• Accounting: Automated workflows for clinical trial close processes, targeting speed, accuracy, and control.
• FP&A: Tools for proactive R&D planning and real-time adaptability in financial decision-making.
• Clinical Operations: Increases visibility across financial and clinical operations, supporting vendor oversight and trial management.
• Internal Audit: Compliance-by-design functionality intended to support fast and thorough internal audit reviews.

Customer Segments

• Emerging and Mid-Sized Biopharma: Designed to scale with organizational complexity while maintaining compliance and reducing risk.
• Enterprise Biopharma: Focused on unifying systems and streamlining planning across large organizations.
• MedTech: Provides financial clarity for device, diagnostic, and digital health trials.
• CRO and Partners: Supports collaboration and shared accountability between sponsors and contract research organizations.

Key Capabilities and Performance Metrics

• Automated accruals, forecasting, budgeting, and benchmarking within a single platform.
• Real-time variance flags and scenario modeling to support portfolio decision-making.
• Reported outcomes include faster close cycles, up to 4x portfolio growth without additional headcount, improvements in forecast accuracy, and average vendor budget savings exceeding a stated threshold, with claims of up to $5 million in clinical program savings.
• Integrations with ERP, CTMS, EDC, and procurement systems to consolidate R&D financial data.

Professional Services and Customer Success

• Condor offers a Professional Services team described as having decades of clinical R&D experience, providing implementation support and ongoing guidance.
• A Customer Success function supports sustained performance across clinical finance operations.
• A referral program is available for existing customers who refer other biotech organizations.

Condor describes itself as having built the industry's first fully automated financial cloud purpose-built for Accounting, Finance, Clinical Operations, and FP&A teams in biopharma. The platform is positioned as a replacement for static spreadsheets and legacy systems, with all workflows designed specifically for the clinical trial finance environment and integrated with the systems life sciences teams already use.